Metraipolis › archive › dc_e07f4ed55fe7

4C-P — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/4C-P
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-06T17:05:51.108Z
SHA-256 of the archived text
c6894dccd5f360d4e7be7cc58bf9d763850fcd2fdc08bceafa388bfd5c82d8d0
Stable URL of this page
https://metraipolis.com/documento/dc_e07f4ed55fe7

How to cite

4C-P — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/4C-P (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_e07f4ed55fe7 (Metraipolis archive dc_e07f4ed55fe7, sha256 c6894dccd5f360d4e7be7cc58bf9d763850fcd2fdc08bceafa388bfd5c82d8d0)
BibTeX
@misc{dce07f4ed55fe7,
  title = {4C-P — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/4C-P},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_e07f4ed55fe7; sha256 c6894dccd5f360d4e7be7cc58bf9d763850fcd2fdc08bceafa388bfd5c82d8d0},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/4C-P. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

4C-P, or 4C-Pr, also known as 4C-DOPR, as well as 4-propyl-2,5-dimethoxy-α-ethylphenethylamine, is a serotonin 5-HT2 receptor agonist of the phenethylamine, phenylisobutylamine, and 4C families related to Ariadne (4C-D). It is a close analogue of the psychedelic drugs 2C-P and DOPR, with 2C-P having no substitution at the α carbon, DOPR having an α-methyl group, and 4C-P having an α-ethyl group. The drug is a potent agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. It shows similar efficacy as an agonist of these receptors as Ariadne, but has about 6.2-fold higher potency as a serotonin 5-HT2A receptor agonist in comparison. Like Ariadne, 4C-P produces an attenuated head-twitch response relative to DOPR, with a similar maximal response as Ariadne. The chemical synthesis of 4C-P has been described. 4C-P was patented in 1977 and first described in the scientific literature by Alexander Shulgin and colleagues in 1980. Subsequently, it was described in greater detail by Michael Cunningham and colleagues in 2023.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «4C-P» — https://en.wikipedia.org/wiki/4C-P
Wikidata Q138529365: «pharmaceutical compound» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q138529365
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/4C-P?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1371210521, consultata il 2026-11-06T17:01:49.650Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 8434eb35628bc82ab53d4ab68246271cd65770702cd5c45b9203d910652ea34a